De Burlo Group Inc Novo Nordisk A S Transaction History
De Burlo Group Inc
- $741 Million
- Q4 2024
A detailed history of De Burlo Group Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, De Burlo Group Inc holds 4,955 shares of NVO stock, worth $327,327. This represents 0.06% of its overall portfolio holdings.
Number of Shares
4,955
Previous 148,730
96.67%
Holding current value
$327,327
Previous $17.7 Million
97.59%
% of portfolio
0.06%
Previous 2.19%
Shares
6 transactions
Others Institutions Holding NVO
# of Institutions
1,877Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.32 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.02 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$858 Million1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$835 Million0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$806 Million0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $149B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...